IJCRRI Journ Cur Res ReInternational Journal of Current Research and ReviewI Journ Cur Res Re2231-21960975-5241Open Science Publishers LLP226https://doi.org/10.31782/IJMPS.2023.13501Pharmaceutical SciencesLipid Nanobiotechnology: An Alternative Strategy to Targeted Drug and Vaccine Delivery System and Its Biomedical Applications as Nanomedicine __ampersandsignnbsp; RamtekeAshish S.11052023)19This article is copyright of Popeye Publishing, 20092009This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.

Nanobiotechnology has very compelling role in vaccine development. Delivery system orientates toward less immunogenic minimal compositions and formulations that boost antigen effectiveness. Latest advancements in LNPs formulations as targeted vaccine delivery systems, like anticancer and nucleic acid therapeutics. Nanomedicine expel challenges and promote growth opportunities inareas, like biomedical imaging, nutraceuticals, biomedicine, gene technology, and basic sciences. The fundamental understanding regarding the in-vivo behavior of nanoparticles explored, which can perform as either a delivery system to enhance antigen processing and/or as an immunostimulant adjuvant to activate or enhance immunity. The utilization of nanoparticles in vaccine development allows targeted delivery, improved antigen stability and immunogenicity.

Lipid nanoparticles Liposome Immunoliposome Targeted delivery Vaccine Nanomedicine